- Report
- November 2024
- 216 Pages
Global
From €4888EUR$4,950USD£4,082GBP
- Report
- November 2024
- 258 Pages
Global
From €4888EUR$4,950USD£4,082GBP
- Report
- November 2024
- 118 Pages
Global
From €5382EUR$5,450USD£4,494GBP
- Report
- November 2024
- 277 Pages
Global
From €5382EUR$5,450USD£4,494GBP
- Report
- November 2024
- 276 Pages
Global
From €5530EUR$5,600USD£4,618GBP
- Report
- November 2024
- 148 Pages
Global
From €5382EUR$5,450USD£4,494GBP
- Report
- November 2024
- 196 Pages
Global
From €5382EUR$5,450USD£4,494GBP
- Report
- November 2024
- 92 Pages
Global
From €5530EUR$5,600USD£4,618GBP
- Report
- November 2024
- 89 Pages
Global
From €5530EUR$5,600USD£4,618GBP
- Report
- November 2024
- 93 Pages
Global
From €5530EUR$5,600USD£4,618GBP
- Report
- November 2024
- 193 Pages
Global
From €5382EUR$5,450USD£4,494GBP
- Report
- November 2024
- 193 Pages
Global
From €5382EUR$5,450USD£4,494GBP
- Report
- June 2024
Global
From €4888EUR$4,950USD£4,082GBP
- Report
- December 2023
- 51 Pages
Global
From €4888EUR$4,950USD£4,082GBP
- Report
- November 2024
- 150 Pages
Global
From €4789EUR$4,850USD£3,999GBP
- Report
- November 2024
- 150 Pages
Global
From €4789EUR$4,850USD£3,999GBP
- Report
- November 2024
- 150 Pages
Global
From €4789EUR$4,850USD£3,999GBP
- Report
- November 2024
- 150 Pages
Global
From €4789EUR$4,850USD£3,999GBP
- Report
- November 2024
- 150 Pages
Global
From €4789EUR$4,850USD£3,999GBP
- Report
- September 2024
- 150 Pages
Global
From €4789EUR$4,850USD£3,999GBP
The Drugs by Therapeutic Area market is a segment of the pharmaceutical industry that focuses on the development and sale of drugs for specific medical conditions. These drugs are designed to treat a wide range of diseases, from cancer to mental health disorders. Companies in this market typically specialize in one or more therapeutic areas, such as oncology, neurology, or cardiology. They develop drugs that target specific medical conditions and then market them to healthcare providers and patients. Companies in this market include Pfizer, Merck, Novartis, GlaxoSmithKline, and Sanofi. Show Less Read more